JPMorgan Chase & Co’s ESSA Pharma EPIX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $321K | Buy |
189,094
+24,219
|
|
||||
2025
Q1 | $261K | Buy |
164,875
+164,854
|
|
||||
2024
Q4 | $38 | Hold |
21
|
|
||||
2024
Q3 | $127 | Hold |
21
|
|
||||
2024
Q2 | $110 | Hold |
21
|
|
||||
2024
Q1 | $178 | Hold |
21
|
|
||||
2023
Q4 | $139 | Sell |
21
-29,406
|
|
||||
2023
Q3 | $90.9K | Sell |
29,427
-14,446
|
|
||||
2023
Q2 | $118K | Sell |
43,873
-15,833
|
|
||||
2023
Q1 | $177K | Buy |
59,706
+50,955
|
|
||||
2022
Q4 | $22K | Sell |
8,751
-64,917
|
|
||||
2022
Q3 | $134K | Sell |
73,668
-206,057
|
|
||||
2022
Q2 | $882K | Buy |
279,725
+202,975
|
|
||||
2022
Q1 | $474K | Buy |
76,750
+62,558
|
|
||||
2021
Q4 | $202K | Buy |
14,192
+199
|
|
||||
2021
Q3 | $112K | Buy |
13,993
+12,417
|
|
||||
2021
Q2 | $45K | Buy |
1,576
+339
|
|
||||
2021
Q1 | $36K | Buy |
1,237
+85
|
|
||||
2020
Q4 | $14K | Sell |
1,152
-3,775
|
|
||||
2020
Q3 | $34K | Buy |
+4,927
|
|